Dolutegravir + Rilpivirine Switch Study (DORISS)

NCT02069834 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped One of the both Funder partners decided to stop the study before the initiation : thus no product provided and no funding to realize the study

Conditions

HIV Infection
HAART-treated
Virologically Controlled

Interventions

DRUG: Arm 1 (intervention)
DRUG: Arm 2 (control)

Sponsor

Nantes University Hospital